Dr. Dai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton Streets
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 646-962-1607
Summary
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2011 - 2014
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2008 - 2011
- Mercy College of OhioPh. D., Molecular Basis of Disease, 1998 - 2003
- Shanghai Medical UniversityClass of 1993
- Shanghai Medical UniversityDoctor of Medicine (M.D.)
Certifications & Licensure
- WA State Medical License Current
- NY State Medical License 2011 - 2026
- CT State Medical License 2017 - 2025
Awards, Honors, & Recognition
- Graduate Student Travel Award for Experimental Biology Meeting American Society for Pharmacology and Experimental Therapeutics (ASPET), 2001
Clinical Trials
- Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) Start of enrollment: 2015 Aug 25
- Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) Start of enrollment: 2015 Nov 30
- High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies Start of enrollment: 2017 Mar 29
- Join now to see all
Publications & Presentations
PubMed
- 539 citationsPhase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164Dung T. Le, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger
Journal of Clinical Oncology. 2020-01-01 - 52 citationsRadiation therapy and the abscopal effect: a concept comes of ageJohn Ng, Tong Dai
Annals of Translational Medicine. 2016-03-01 - 3 citationsAugmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.Rachel Evans, Kelvin Lee, Paul K Wallace, Mary Reid, Jason Muhitch
Frontiers in Oncology. 2022-01-01
Journal Articles
- A phase 2, open-label, study of single agent pembrolizumab in treatment refractory mismatch repair deficient metastatic colorectal cancer: the KEYNOTE-164 study.1. Le D; Kim, TW; Van Cutsem E; Geva R; Jaeger D; Hara H; Burge M; O’Neill B; Kavan P; Yoshino T; Guimbaud R; Taniguchi H; Elez E; Al-Batran SE; Boland PM; Crocenzi T;..., Journal of Clinical Oncology, 8/6/2019
- The Role of 18F-FDG PET Imaging in Upper Gastrointestinal MalignanciesDai T, Popa E, Shah MA, Curr Treat Options Oncol, 7/27/2014
- Ruxolitinib Withdrawal Syndrome Leading to Tumor LysisDai T, Friedman EW, and Barta SK, Journal of Clinical Oncology, 10/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A case of malignant nerve sheath tumor presenting as metastatic cancer.Dai T, American College of Physicians, Connecticut Chapter, 1/1/2009
- Role of CEACAM2 in Insulin Action.Schroeder-Gloeckler JM, DeAngelis AM, Dai T, Heinrich G, Al-Share QY, et al, American Diabetes Association, Chicago, IL, 1/1/2007
- Differential role of CEACAM proteins in regulating insulin action.Dai T, Kim H-J, Fernstrom MA, Park S-Y, Shulman GI, Kim JK, and Najjar SM, ADA Late-breaking Abstract, New Orleans, LA, 1/1/2003
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
External Links
- Cornell websitehttp://weillcornell.org/tongdai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: